Pharmaceutical
May 4, 2006
Shareholders of pharmaceutical company Pfizer Inc. rejected a call recently to oust some members of the company''s board for approving a deal to pay its chief executive officer as much
Read More
April 10, 2006
Swiss biotechnology company Serono, the focus of takeover speculation for months, said it was no longer up for sale because offers had fallen short of its value, the Associated Press
Read More
March 27, 2006
Bayer AG''s 16.3 billion euro ($19.6 billion) offer for drugmaker Schering AG was embraced by its target last week as German rival Merck abandoned its own takeover offer, the Associated
Read More
March 23, 2006
A courthouse in Atlantic City where a case is being heard against drug company Merck & Co. over pain-relieving drug Vioxx was evacuated March 22 after a suspicious device
Read More
March 6, 2006
The Associated Press reports that Atlantic City casino workers will help decide whether drug manufacturer Merck & Co. is to blame for heart attacks suffered by two New Jersey men
Read More
February 20, 2006
A federal jury handed Merck & Co. a major victory last Friday, clearing the drug maker of any responsibility in the death of a 53-year-old Florida man who had a
Read More
February 20, 2006
Croatian drug maker Pliva recently sold its research and development center to GlaxoSmithKline PLC in a deal worth up to US$50 million (euro60 million). According to the Associated Press, Pliva
Read More
January 23, 2006
Although New Orleans has fewer than half the residents it did before Hurricane Katrina, the judge hearing the first federal Vioxx trial has told attorneys he does not expect any
Read More
January 10, 2006
GlaxoSmithKline PLC said it is seeking preliminary approval in Europe to market a vaccine against pandemic influenza, which experts fear may be triggered by bird flu, the Associated Press reports.
Read More
November 29, 2005
Faced with thousands of Vioxx lawsuits, the loss of patent protection for a key product and a weak array of drugs in development, Merck & Co. is axing more than
Read More